IQVCongressional Stock Trades
IQVIA Holdings Inc.
Services-Commercial Physical & Biological Research
Congressional stock trades in IQVIA Holdings Inc. (IQV) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
6
Politicians Trading
3
Last Traded
Dec 29, 2025
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Robert BresnahanR | May 8, 2025 | Apr 8, 2025 | Buy | $15,001 - $50,000 | +84.39% |
Price History
About IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.